Sea Mild Biotechnology Co., Ltd. (TPEX:7516)

Sea Mild Biotechnology Revenue

In the year 2025, Sea Mild Biotechnology had annual revenue of 341.94M TWD with 7.25% growth. Sea Mild Biotechnology had revenue of 176.34M in the half year ending December 31, 2025, with 32.06% growth.

• Revenue: 341.94M
• Revenue Growth: +7.25%
• P/S Ratio: 0.53
• Revenue / Employee: n/a
• Employees: 59
• Market Cap: 179.57M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	341.94M	23.11M	7.25%
Dec 31, 2024	318.82M	61.81M	24.05%
Dec 31, 2023	257.02M	54.37M	26.83%
Dec 31, 2022	202.65M	38.83M	23.71%
Dec 31, 2021	163.82M	-44.06M	-21.20%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 2, 2026

Data Sources Report a data error